About Rochelle Walensky, MD, MPH

Watch a video about my work

Dr. Rochelle Walensky, MD, MPH, is Professor of Medicine at Harvard Medical School and a practicing Infectious Disease physician at Massachusetts General Hospital and Brigham and Women's Hospital.

Dr. Walensky's research interests focus on model-based analyses of the cost-effectiveness of HIV testing, care, and prevention strategies to inform HIV/AIDS policy internationally and domestically.

Using both traditional novel methods of microsimulation modeling and decision analysis, Dr. Walensky has been active in and nationally recognized for motivating health policy and informing clinical trial design and evaluation in a variety of settings.

In addition, Dr. Walensky has been influential in advancing international health policy towards the promotion of HIV treatment as prevention (TasP) and the adoption of other effective and efficient strategies of HIV care.

Dr. Walensky serves as Chair of the Office of AIDS Research Advisory Council (NIH) and as a member of the US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. 

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Infectious Disease Associates
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-3467

Medical Education

  • Harvard T. H. Chan School of Public Health
  • MD, Johns Hopkins University School of Medicine
  • Residency, The Johns Hopkins Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Infectious Disease, American Board of Internal Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Rochelle Walensky, MD, MPH, is the Chief of Infectious Diseases at MGH and Professor of Medicine at Harvard Medical School. Dr. Walensky’s research interests have focused on HIV/AIDS policy and cost-effective strategies of HIV care in the US and in resource-limited settings; she is internationally recognized for motivating US and global policy toward routine HIV screening. She is a member of the American Society for Clinical Investigation, the American Association of Physicians, and the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, and she is past Chair of the NIH Office of AIDS Research Advisory Council.  She has also been an advisor to the WHO and UNAIDS.  Dr. Walensky received her M.D. from the Johns Hopkins School of Medicine and her M.P.H. from the Harvard School of Public Health.  She trained in Internal Medicine at the Johns Hopkins Hospital and in Infectious Diseases at the MGH/BWH combined fellowship program. 

Publications

  • View my most recent publications at PubMed

    Selected References:

    1. Walensky RP, Sax PE, Nakamura YM, Weinstein MC, Pei PP, Freedberg KA, Paltiel AD, Schackman BR.  Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States.  Ann Intern Med. 2013 Jan 15; 158(2):84-92.
    2. Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Want L, McCauley M, Gamble T, Seage GR, Cohen MS, Freedberg KA. The cost-effectiveness of HIV treatment as prevention: analysis of HPTN 052. N Eng J Med. 2013; 369(18):1715–1725.